Xeomin has been used in clinical practice for more than 10 years, with over 127,000 people having received injections of this drug, and to date, not a single patient has been identified who failed to show a secondary clinical response.
On the correction of mimic wrinkles and age-related changes in the upper third of the face (forehead, glabella, eyebrows, eyes, nose) using botulinum toxin type A.
About the project
EstPortal.com (Aesthetic Portal) – is a professional resource dedicated to beauty. The project will be of interest to both beauty industry specialists and its connoisseurs. The aim of the project: to provide maximum time saving on search of necessary information for beauty industry specialists and site visitors.